ArticleEuropean journal of drug metabolism and pharmacokinetics2026
Early Trough Prediction Error of Japanese Population Pharmacokinetic Models for Teicoplanin After Loading in Cancer Patients.
Article in European journal of drug metabolism and pharmacokinetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivePublished Japanese population pharmacokinetic parameter sets are used for teicoplanin dosing, but their accuracy for teicoplanin trough concentrations in patients with cancer is unclear. This study evaluated agreement between a priori predicted and measured teicoplanin trough concentrations after loading in patients with cancer and identified clinical factors associated with prediction error.
methodsWe retrospectively studied 217 patients with cancer receiving fixed loading (600 mg twice on days 1 and 2 and 600 mg once on day 3) with a day 4 trough measurement. Day 4 trough concentrations were predicted a priori using three Japanese population pharmacokinetic parameter sets. Prediction error was defined as predicted minus measured (mg/l). Multivariable linear regression evaluated associations with febrile neutropenia status and creatinine clearance (CCr).
resultsMean prediction error ranged from -5.30 to -1.85 mg/l, indicating underprediction. Underprediction was greater in patients without febrile neutropenia (-7.12 to -2.98 mg/l) than in those with febrile neutropenia (-3.21 to -0.54 mg/l). In multivariable models, febrile neutropenia (vs absence) was associated with less negative prediction error (+4.85 to +5.27 mg/l; all P < 0.001). Higher CCr was associated with more negative prediction error (-0.32 to -0.72 mg/l per 10 ml/min; all P < 0.001), indicating greater underprediction at higher CCr.
conclusionsJapanese parameter sets underestimated day 4 teicoplanin trough concentrations after loading in patients with cancer, and prediction error differed by febrile neutropenia status after adjustment for CCr. Early trough measurement after loading should therefore be considered when these parameter sets are used.
Identifiers
42909574What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.